Michael S. Poirier, Chairman, CEO & President at Qualigen Therapeutics, Inc. (QLGN), bought 11,005 shares at $1.80 ($20K) on 2021-04-20, disclosed to the SEC on 2021-04-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.